Design and Synthesis of Biphenyl Derivatives As Mushroom Tyrosinase Inhibitors

Kai Bao,Yi Dai,Zhi-Bin Zhu,Feng-Juan Tu,Wei-Ge Zhang,Xin-Sheng Yao
DOI: https://doi.org/10.1016/j.bmc.2010.07.062
IF: 3.461
2010-01-01
Bioorganic & Medicinal Chemistry
Abstract:Two new series of biphenyls, analogs of aglycone of natural product fortuneanoside E, were prepared using Suzuki–Miyaura cross-coupling and selective magnesium iodide demethylation/debenzylation, and their mushroom tyrosinase inhibitory activity was evaluated. Most of the 4-hydroxy-3,5-dimethoxyphenyl biphenyl compounds (series II, 20–36) were in general more active than 3,4,5-trimethoxyphenyl biphenyl compounds (series I, 1–19). Structure–activity relationships study showed that monosaccharide substituents, such as glucose, were not necessary and the presence of 4-hydroxy-3,5-dimethoxyphenyl moiety was crucial for inhibitory activity. Among the compounds synthesised, compound 21 (IC50 = 0.02 mM) was found to be the most active one, which exhibited an activity that was 7 times higher than that of fortuneanoside E (IC50 = 0.14 mM) and 10 times higher than that of arbutin (IC50 = 0.21 mM), known as potent tyrosinase inhibitors. The inhibition kinetics analyzed by Lineweaver–Burk plots revealed that compound 21 was a competitive inhibitor (Ki = 0.015 mM).
What problem does this paper attempt to address?